CA Patent

CA2821756C — Sublingual films comprising apomorphine and an organic base

Assigned to Sumitomo Pharma America Inc · Expires 2021-06-29 · 5y expired

What this patent protects

Abstract The invention features sublingual film formulations comprising apomorphine hydrochloride and pyridoxine, and methods of treating Parkinson's disease and restless leg syndrome. 31374965.2 Date Recue/Date Received 2021-02-04

USPTO Abstract

Abstract The invention features sublingual film formulations comprising apomorphine hydrochloride and pyridoxine, and methods of treating Parkinson's disease and restless leg syndrome. 31374965.2 Date Recue/Date Received 2021-02-04

Drugs covered by this patent

apomorphine-hydrochloride (APOMORPHINE HYDROCHLORIDE)

Patent Metadata

Patent number: CA2821756C
Jurisdiction: CA
Classification: —
Expires: 2021-06-29
Drug substance claim: No
Drug product claim: No
Assignee: Sumitomo Pharma America Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.